Viral hepatitis is a frequent cause of decompensated
cirrhosis, which starts as compensated cirrhosis in which there are no symptoms of the scarring of the liver (cirrhosis).
When liver function worsens and presents with symptoms such as jaundice, malaise, ascites, edema, hepatic encephalopathy, it is called decompensated
Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated
Heart Failure National Registry (ADHERE).
A 49-year-old man was admitted to the intensive care unit due to decompensated
exophoria at near is easiest to treat with eye exercise.
A high-sodium diot is associated with acute decompensated
heart failure in ambulatory heart failure patients: a prospective follow-up study.
Approval was based on data from an ongoing study that randomized patients with chronic hepatitis B and decompensated
liver disease to treatment with entecavir, at a dose of 1 mg once daily, or the nucleotide analogue adefovir (10 mg once daily), according to a statement issued by Bristol-Myers Squibb (BMS).
SAN DIEGO -- Plasma levels of serotonin were significantly elevated in patients with decompensated
systolic heart failure, compared with patients in the compensated state and with normal controls, according to a single-center study.
a clinical stage pharmaceutical company developing therapeutic agents for the treatment of acute decompensated
heart failure (ADHF) and other cardiovascular diseases, announced the presentation of a comprehensive review of the pharmacological effects of nitroxyl (HNO) in the treatment of ADHF.
The adjudicator confirmed the diagnosis of decompensated
HF when it was a primary discharge diagnosis, when other causes of dyspnea were absent, and when the treatment plan was consistent with decompensated
The drug is approved to treat patients with acutely decompensated
congestive heart failure who experience shortness of breath.
Director, Advanced Heart Failure Treatment Program, University of California San Diego Medical Center, and National Principal Investigator for the MOMENTUM Trial, presented, "Efficacy and Safety of Continuous Aortic Flow Augmentation in Patients Hospitalized with Acute Decompensated
Heart Failure: Results of the MOMENTUM Trial.